The cigarette producer has announced a second impairment charge in three months to a $12.8bn investment now valued at only $4.2bn.

The online pharmacy is set to announce a series D round that will be led by $250m from SoftBank Vision Fund at a valuation in excess of $1bn.

The GV-backed primary care membership service floated at the bottom of its range but garnered a valution of more than $1.7bn.

Corporate units Axa Venture Partners, MassMutual Ventures and Transamerica Ventures all returned for a round that nearly trebled the insurance marketplace's overall funding.

Alphabet unit Verily has taken part in an oversubscribed series B round that will fund Mammoth Biosciences' expansion from diagnostics to gene editing and drug development.

Hewlett Packard Enterprise contributed to a $37.5m round that represents the second to be publicly dislcosed by the IT management software provider.

Waters Corporation reinvested in the protein characterisation technology producer through an oversubscribed round that will fund innovation and expansion.

Mireille Helou and Adam Sterling talked about ways Orange will remain innovation-driven in the future.

Jason Illian described how connecting, engaging and serving entrepreneurs created value.

Data-based worldwide corporate venture capital trends were presented by Martin Haemmig.